Palvella Therapeutics Inc (PVLA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Sales | 19,520 | 20,055 | 1,936 | 5,846 | 5,370 |
| Gross Profit | 19,520 | 20,055 | 1,936 | 5,846 | 5,370 |
| Operating Expenses | 31,327 | 17,992 | 17,447 | 17,365 | 17,538 |
| Operating Income | -11,807 | 2,063 | -15,511 | -11,519 | -12,168 |
| Other Income | 1,055 | 1,913 | 2,328 | 3,417 | 2,432 |
| Pre-tax Income | -10,752 | 3,976 | -13,183 | -8,102 | -9,736 |
| Net Income Continuous | -10,752 | 3,976 | -13,183 | -8,102 | -9,736 |
| Net Income | $-10,752 | $3,976 | $-13,183 | $-8,102 | $-9,736 |
| EPS Basic Total Ops | -8.70 | 3.63 | -14.15 | -8.80 | -10.40 |
| EPS Basic Continuous Ops | -8.70 | 3.63 | -14.16 | -8.73 | -10.47 |
| EPS Diluted Total Ops | -8.70 | 3.62 | -14.15 | -8.80 | -10.40 |
| EPS Diluted Continuous Ops | -8.70 | 3.62 | -14.16 | -8.73 | -10.47 |
| EBITDA(a) | $-11,068 | $2,821 | $-14,906 | $-10,944 | $-11,401 |